05/18/2017
Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.
05/01/2017
The Bio-Plex Pro™ Human Apolipoprotein Panel allows researchers to detect nine key apolipoproteins and C-reactive protein — targets important for cardiovascular and neurobiology research — all in a single well.
04/19/2017
Bio-Rad Releases Labeled Antibodies for Fluorescent Multiplex Detection of Proteins in Western Blots
StarBright™ Blue 700 Secondary Antibodies offer highly sensitive fluorescent detection, short exposure times, and easy multiplexing for western blotting. hFAB™ Rhodamine Primary Antibodies offer a reliable and easy method for one-step detection of common housekeeping proteins.
04/04/2017
Bio-Rad Laboratories, Inc. announced that its ZE5™ Cell Analyzer was named the "Best New Product/Service" during International Pharmaceutical Expo (INTERPHEX) held in New York last month.
04/03/2017
Researchers will present more than 50 new studies at AACR. Building on last year’s trend, many will showcase the power of Droplet Digital PCR technology for detecting biomarkers in cancer liquid biopsies.
03/14/2017
Bio-Rad Laboratories awards four researchers $25,000 worth of Bio-Rad consumables each to advance their pioneering research using Droplet Digital™ PCR technology.
03/14/2017
Digital PCR reproducibly quantified an important cancer mutation across 21 laboratories, highlighting the potential for clinical use.
02/07/2017
The Bio-Plex Pro™ Mouse Chemokine Panel enables researchers to detect more samples than any other available assay, allowing them to get more data out of each run.
02/02/2017
Bio-Rad’s ChemiDoc MP Imaging System enables fluorescent digital imaging for efficient quantitation of multiple protein targets on the same membrane.
01/22/2017
Translational researchers and clinicians will present research demonstrating when and how digital PCR technology and next-generation sequencing can be used with liquid biopsies for treating cancer.